4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-028807
Chief Operating Officer sold 1,801 shares at an average $20.09 ($36,179)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2024-03-06 | Sale 10b5-1 | −1,733 | $20.09 | $34,819 | 431,951 | D |
| Bensen Daniel Chief Operating Officer | 2024-03-07 | Sale 10b5-1 | −68 | $20.00 | $1,360 | 431,883 | D |
| Open-market sales · 1,801 sh · avg $20.09 · $36,179 | |||||||
Loading xslF345X05/ownership.xml…